 ChemoCentryx Inc NASDAQ: CCXI shares are trading lower by 12.8 at 25.70 Wednesday morning after the company reported worse-than-expected fourth-quarter EPS and sales results. ChemoCentryx reported quarterly losses of 58 cents per share which missed the analyst consensus estimate of a loss of 50. 